GlobeNewswire: Indiana Biosciences Research Institute Contains the last 10 of 17 releaseshttp://www.globenewswire.com/External?Length=42024-03-29T01:27:10ZGlobeNewswirehttp://www.globenewswire.com/External?Length=4newsdesk@globenewswire.com (NewsDesk)https://www.globenewswire.com/news-release/2019/07/29/1893031/0/en/IBRI-announces-research-team-for-its-Diabetes-Center.html?f=22&fvtc=4&fvtv=29726IBRI announces research team for its Diabetes Center2019-07-29T14:58:59Z<![CDATA[INDIANAPOLIS, July 29, 2019 (GLOBE NEWSWIRE) -- The Indiana Biosciences Research Institute (IBRI) today announced new investigators for the IBRI Diabetes Center (IDC).]]>https://www.globenewswire.com/news-release/2019/06/20/1872154/0/en/IBRI-in-license-agreement-for-access-to-Lilly-s-Fab-Phage-Display-Library.html?f=22&fvtc=4&fvtv=29726IBRI in license agreement for access to Lilly’s Fab Phage Display Library2019-06-20T20:07:10Z<![CDATA[Will speed the discovery and validation of new antibodies to improve human health Will speed the discovery and validation of new antibodies to improve human health]]>https://www.globenewswire.com/news-release/2019/04/04/1797353/0/en/IBRI-issues-its-digital-and-print-2018-Annual-Report-Discovery-With-Purpose-Diabetes-biopharmaceutical-research-and-health-data-analytics-research-expanded.html?f=22&fvtc=4&fvtv=29726IBRI issues its digital and print 2018 Annual Report, “Discovery With Purpose” Diabetes, biopharmaceutical research and health data analytics research expanded2019-04-04T19:35:47Z<![CDATA[INDIANAPOLIS, April 04, 2019 (GLOBE NEWSWIRE) -- The Indiana Biosciences Research Institute (IBRI) today announced the release of its print and digital 2018 Annual Report. The report theme is “Discovery With Purpose,” which is also the IBRI’s motto as it reflects the Institute’s commitment to translating scientific discovery into improved outcomes for patients.]]>https://www.globenewswire.com/news-release/2019/01/28/1706289/0/en/Indiana-Biosciences-Research-Institute-collaboration-helps-discover-new-genetic-disease.html?f=22&fvtc=4&fvtv=29726Indiana Biosciences Research Institute collaboration helps discover new genetic disease2019-01-28T16:28:51Z<![CDATA[INDIANAPOLIS, Jan. 28, 2019 (GLOBE NEWSWIRE) -- A collaborative research project led in part by the Indiana Biosciences Research Institute (IBRI) has resulted in the first description of a new monogenic disease, named, “DHPS Deficiency.”]]>https://www.globenewswire.com/news-release/2019/01/09/1685269/0/en/Nature-Medicine-Publishes-Local-and-International-Companies-Major-Data-Analytics-Study-of-Type-2-Diabetes.html?f=22&fvtc=4&fvtv=29726Nature Medicine Publishes Local and International Companies’ Major Data Analytics Study of Type 2 Diabetes2019-01-09T20:59:58Z<![CDATA[Findings are the result of a year-long collaboration of Roche Diabetes Care GmbH, IBM, Eli Lilly and Company, the Regenstrief Institute and the Indiana Bioscience Research Institute Findings are the result of a year-long collaboration of Roche Diabetes Care GmbH, IBM, Eli Lilly and Company, the Regenstrief Institute and the Indiana Bioscience Research Institute]]>https://www.globenewswire.com/news-release/2018/12/05/1662650/0/en/University-of-Notre-Dame-and-Indiana-Biosciences-Research-Institute-partner-to-address-health-concerns.html?f=22&fvtc=4&fvtv=29726University of Notre Dame and Indiana Biosciences Research Institute partner to address health concerns2018-12-05T18:04:31Z<![CDATA[NOTRE DAME, Ind., Dec. 05, 2018 (GLOBE NEWSWIRE) -- The University of Notre Dame and the Indiana Biosciences Research Institute (IBRI) have signed a strategic alliance agreement to encourage collaborations between Notre Dame and IBRI researchers. The alliance will enable both organizations to work together on research covering significant health issues in Indiana and around the world.]]>https://www.globenewswire.com/news-release/2018/11/07/1647181/0/en/Virtusa-Partners-with-the-IBRI-to-Drive-Innovation-and-Accelerate-Therapy-Research.html?f=22&fvtc=4&fvtv=29726Virtusa Partners with the IBRI to Drive Innovation and Accelerate Therapy Research2018-11-07T16:05:41Z<![CDATA[SOUTHBOROUGH, Mass., Nov. 07, 2018 (GLOBE NEWSWIRE) -- Virtusa Corporation (NASDAQ GS:VRTU), a global provider of digital strategy, digital engineering, and IT outsourcing services that accelerates business outcomes for its clients, today announced its collaboration with the Indiana Biosciences Research Institute (IBRI) to accelerate Life Sciences research and development. This partnership will leverage Virtusa’s vLife open innovation platform to enable organizations to work in a connected ecosystem that allows them to access, validate, and adopt other firms’ technologies (e.g. analytics, machine learning, artificial intelligence) and enhance the entire research and development process.]]>https://www.globenewswire.com/news-release/2018/09/14/1571062/0/en/New-Lilly-Diabetes-Center-of-Excellence-Established-at-the-Indiana-Biosciences-Research-Institute.html?f=22&fvtc=4&fvtv=29726New Lilly Diabetes Center of Excellence Established at the Indiana Biosciences Research Institute2018-09-14T11:53:18Z<![CDATA[New center will be a central Indiana nexus for advanced diabetes research and talent attraction]]>https://www.globenewswire.com/news-release/2018/05/29/1513394/0/en/Indiana-Biosciences-Research-Institute-names-vice-president-for-advancement.html?f=22&fvtc=4&fvtv=29726Indiana Biosciences Research Institute names vice president for advancement2018-05-29T17:08:35Z<![CDATA[INDIANAPOLIS, May 29, 2018 (GLOBE NEWSWIRE) -- The Indiana Biosciences Research Institute (IBRI) today announced the appointment of Stephanie Grinage as vice president for Advancement. As IBRI’s top development officer, she will serve as the primary strategic partner in cultivating and maintaining new and existing relationships with major donors and oversee and manage all aspects of IBRI’s fundraising programs. She will assume this role with the IBRI June 4, 2018.]]>https://www.globenewswire.com/news-release/2018/05/21/1509541/0/en/Indiana-Biosciences-Research-Institute-names-executive-director-of-engagement-communications-and-external-affairs.html?f=22&fvtc=4&fvtv=29726Indiana Biosciences Research Institute names executive director of engagement, communications and external affairs2018-05-21T16:16:13Z<![CDATA[INDIANAPOLIS, May 21, 2018 (GLOBE NEWSWIRE) -- The Indiana Biosciences Research Institute (IBRI) today announced the appointment of Mark E. Craft as executive director of engagement, communications and external affairs, effective April 23, 2018. In this role, Craft works closely with the senior management team directing the Institute’s strategic and external communications. He also supports the CEO and vice president for advancement for overall engagement with key constituents, including potential donors and partners.]]>